News

June 25, 2019June 25, 2019

Deal Plans to Make Yupelri Treatment Available in China and Adjacent Territories

News

Theravance Biopharma and Mylan have agreed to extend the development and commercialization of Yupelri (inhalation solution of revefenacin) — the first and only once-daily nebulized bronchodilator approved for chronic ... Read more

June 21, 2019June 21, 2019

Electronic Monitoring of Inhaler Use Reduces Hospitalizations, Study Suggests

News

New research suggests that monitoring inhaler usage electronically can reduce the number of hospital stays needed by people with chronic obstructive pulmonary disease (COPD). The study, titled “Electronic inhaler ... Read more

June 19, 2019June 19, 2019

Oxygen Manifesto, Part 2: the Devices (Advice from 3 Respiratory Specialists)

News

Note: This is the second article in a three-part series written in collaboration with respiratory therapist Mark W. Mangus Sr., RRT, RPFT, FAARC, and oxygen expert Ryan Diesem. The ... Read more

June 18, 2019June 18, 2019

Boehringer Ingelheim, Alberta Government Create Partnership to Improve Patient Care

News

Boehringer Ingelheim, the University Hospital Foundation, and the Government of Alberta, Canada, have formed a partnership aimed at implementing effective solutions to improve the lives of people with respiratory ... Read more

June 14, 2019June 14, 2019

Use of Inhaled Steroids May Reduce Lung Cancer Risk in COPD, Study Suggests

News

The use of inhaled steroids reduces the risk of developing lung cancer in people with chronic obstructive pulmonary disease (COPD), a study suggests. The study, titled “Inhaled corticosteroids and ... Read more

June 11, 2019June 11, 2019

Add-on Fasenra Does Not Ease COPD Exacerbations, Phase 3 Results Show

News

Add-on treatment with asthma medication Fasenra (benralizumab) failed to reduce annual exacerbations in patients with moderate to very severe chronic obstructive pulmonary disease (COPD), according to final results of two Phase ... Read more

June 7, 2019June 7, 2019

Georgia Hospital Using Zephyr Valve System to Treat Breathing Problems Due to Emphysema

News

Piedmont Atlanta announced that it is the first hospital in the state of Georgia to offer treatment for emphysema with the Zephyr Valve System, a minimally invasive therapy for ... Read more

June 4, 2019June 4, 2019

Analysis Shows Effectiveness of Verona’s Ensifentrine Treatment on COPD Symptoms

News

A post-hoc analysis showed that nebulized ensifentrine (RPL544) is highly effective for relieving respiratory symptoms in chronic obstructive pulmonary disease (COPD) patients with either reversible or non-reversible airway obstruction, although ... Read more

May 28, 2019May 28, 2019

Verona Starts Phase 2b Trial to Test Nebulized Ensifentrine as Add-on Therapy

News

Verona Pharma started a Phase 2b dose-ranging study testing the safety and efficacy of nebulized ensifentrine (RPL554) as an add-on to a standard long-acting bronchodilator in people with moderate to ... Read more

May 24, 2019May 24, 2019

Azithromycin May Reduce Treatment Failure After COPD Exacerbations

News

Azithromycin treatment initiated during hospitalization for an acute exacerbation of chronic obstructive pulmonary disease (COPD), followed by three months of a low-maintenance dose, seems to reduce treatment failure. The results ... Read more

Pin It on Pinterest